Massachusetts 2023-2024 Regular Session

Massachusetts House Bill H1156

Introduced
2/16/23  
Refer
2/16/23  

Caption

Relative to opioid use disorder treatment and rehabilitation coverage

Impact

The implementation of H1156 will likely have a substantial impact on how substance use disorder treatment is accessed in Massachusetts. By requiring that insurance providers cover opioid-related treatments more comprehensively, the bill aims to increase access to essential care for individuals struggling with addiction. This could lead to a decrease in the number of overdose deaths and improve overall public health outcomes, as individuals would have easier access to life-saving medications and treatments. Furthermore, the bill addresses the issue of opioid antagonists' availability post-discharge from treatment facilities, reinforcing a preventive approach towards potential relapses and overdoses.

Summary

House Bill H1156 aims to enhance the coverage for opioid use disorder treatment and rehabilitation services within Massachusetts. The bill proposes amendments to several sections of the General Laws, particularly concerning the coverage provided by the Group Insurance Commission and specific insurance policies. It mandates that coverage for prescribed opioid antagonists and agonist treatments be deemed medically necessary, with no prior authorization required and without additional financial burdens like deductibles or copayments. This ensures that individuals seeking treatment will face fewer barriers due to cost and bureaucratic authorization processes.

Contention

Though primarily aimed at improving healthcare access, H1156 may encounter opposition based on funding and resource allocation concerns. Detractors might argue about the fiscal implications of mandating comprehensive coverage, particularly on the state budget and insurance premiums. Additionally, there may be differing opinions on the specific types of treatments covered under the bill, as stakeholders including healthcare providers, insurance companies, and patient advocacy groups could have varying perspectives on what constitutes adequate treatment. Ensuring that the law is equitable and effective in real-world applications would require ongoing discussions among all involved parties.

Companion Bills

MA H2184

Similar To Authorizing pharmacists to provide opioid use disorder treatment

MA H1998

Similar To Relative to reducing the risk of unintended fatal opioid overdose

MA H4879

Replaced by Study Order

Previously Filed As

MA H2239

Relative to ensuring the privacy of the residents living in sober homes

MA H1337

Relative to opioid use disorder treatment and rehabilitation coverage

MA H1669

Relative to the effective enforcement of municipal ordinances and by-laws

Similar Bills

CT HB07395

An Act Concerning Opioid Abuse And Treatment.

MA H1337

Relative to opioid use disorder treatment and rehabilitation coverage

CT HB05430

An Act Concerning Opioids.

CO HB1037

Substance Use Disorders Harm Reduction

CT SB00483

An Act Concerning The Prevention And Treatment Of Opioid Dependency And Opioid Overdoses In The State.

CA AB423

Alcoholism or drug abuse recovery or treatment programs and facilities: disclosures.

IL SB3350

FENTANYL TEST STRIPS

TX HB3285

Relating to programs and initiatives to prevent and respond to opioid addiction, misuse, abuse, and overdose and identify and treat co-occurring substance use disorders and mental illness.